Total Payments
$11,337
2024 Payments
$1,801
Companies
44
Transactions
551
Medicare Patients
1,927
Medicare Billing
$257,361
Payment Breakdown by Category
Food & Beverage$10,534 (92.9%)
Consulting$450.00 (4.0%)
Travel$234.40 (2.1%)
Education$117.93 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,534 | 545 | 92.9% |
| Consulting Fee | $450.00 | 3 | 4.0% |
| Travel and Lodging | $234.40 | 1 | 2.1% |
| Education | $117.93 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,594 | 145 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,185 | 63 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $995.66 | 56 | $0 (2024) |
| PFIZER INC. | $741.72 | 36 | $0 (2024) |
| Boston Scientific Corporation | $511.20 | 7 | $0 (2023) |
| Biogen, Inc. | $450.00 | 3 | $0 (2023) |
| Allergan Inc. | $443.74 | 45 | $0 (2018) |
| Gilead Sciences, Inc. | $403.41 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $382.68 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $336.08 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,801 | 69 | Janssen Biotech, Inc. ($310.96) |
| 2023 | $1,543 | 68 | AbbVie Inc. ($289.91) |
| 2022 | $1,699 | 73 | ABBVIE INC. ($391.71) |
| 2021 | $755.01 | 30 | AbbVie Inc. ($211.59) |
| 2020 | $215.27 | 13 | AbbVie Inc. ($57.99) |
| 2019 | $2,235 | 96 | AbbVie, Inc. ($567.92) |
| 2018 | $2,056 | 115 | AbbVie, Inc. ($598.15) |
| 2017 | $1,034 | 87 | AbbVie, Inc. ($202.94) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 4 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/01/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/16/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Gastroenterology | ||||||
| 10/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: CNS | ||||||
| 10/17/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/03/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/18/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Immunology | ||||||
| 08/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Gastroenterology | ||||||
| 08/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 07/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Gastroenterology | ||||||
| 07/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/11/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Gastroenterology | ||||||
| 07/05/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/05/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/29/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 317 | 317 | $408,396 | $43,716 |
| 2022 | 9 | 448 | 450 | $565,369 | $57,997 |
| 2021 | 12 | 478 | 478 | $588,252 | $67,125 |
| 2020 | 17 | 684 | 687 | $833,944 | $88,523 |
Total Patients
1,927
Total Services
1,932
Medicare Billing
$257,361
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 85 | 85 | $140,250 | $16,262 | 11.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 44 | 44 | $53,900 | $7,586 | 14.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 32 | 32 | $38,208 | $5,493 | 14.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $39,450 | $4,210 | 10.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $49,455 | $3,795 | 7.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 20 | 20 | $23,736 | $2,087 | 8.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $27,988 | $1,796 | 6.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $30,564 | $1,756 | 5.7% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 15 | 15 | $4,845 | $731.10 | 15.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 103 | 103 | $169,950 | $18,502 | 10.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 55 | 55 | $65,670 | $9,596 | 14.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 64 | 64 | $84,160 | $8,954 | 10.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 35 | 35 | $42,875 | $6,049 | 14.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $63,585 | $4,667 | 7.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 46 | 46 | $43,838 | $3,400 | 7.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 51 | 51 | $57,732 | $3,361 | 5.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 24 | 26 | $29,484 | $2,195 | 7.4% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 25 | 25 | $8,075 | $1,273 | 15.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 110 | 110 | $181,500 | $21,745 | 12.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 67 | 67 | $87,073 | $9,551 | 11.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 39 | 39 | $46,566 | $7,201 | 15.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2021 | 11 | 11 | $29,348 | $6,791 | 23.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 54 | 54 | $76,302 | $5,135 | 6.7% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 53 | 53 | $49,736 | $4,072 | 8.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 21 | 21 | $25,725 | $3,883 | 15.1% |
About Dr. Ronald Schwarz, MD
Dr. Ronald Schwarz, MD is a Gastroenterology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508905043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Schwarz, MD has received a total of $11,337 in payments from pharmaceutical and medical device companies, with $1,801 received in 2024. These payments were reported across 551 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,534).
As a Medicare-enrolled provider, Schwarz has provided services to 1,927 Medicare beneficiaries, totaling 1,932 services with total Medicare billing of $257,361. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Raleigh, NC
- Active Since 02/05/2007
- Last Updated 01/29/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1508905043
Products in Payments
- XIFAXAN (Drug) $823.62
- ENTYVIO (Biological) $635.27
- ZEPOSIA (Drug) $525.29
- STELARA (Biological) $523.86
- TYSABRI (Biological) $450.00
- SKYRIZI (Biological) $441.08
- DUPIXENT (Biological) $397.19
- XELJANZ (Drug) $373.65
- LINZESS (Drug) $372.43
- Cimzia (Drug) $310.14
- Humira (Biological) $295.19
- Entyvio (Biological) $261.29
- GENERAL THERAPIES (Device) $234.40
- INFLECTRA (Biological) $220.14
- Creon (Drug) $218.50
- XIFAXANIBSD (Drug) $211.44
- HUMIRA (Biological) $199.81
- TRULANCE (Drug) $198.02
- ZENPEP (Drug) $197.45
- RINVOQ (Biological) $176.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Raleigh
Sanjay Jagannath, M.d, M.D
Gastroenterology — Payments: $68,773
Gastroenterology $68,773
Dr. Alyson Johnson, Md, MD
Gastroenterology — Payments: $51,083
Gastroenterology $51,083
Dr. Rig Patel, Md, MD
Gastroenterology — Payments: $45,372
Gastroenterology $45,372
Dr. Henry Vanpala, M.d, M.D
Gastroenterology — Payments: $43,522
Gastroenterology $43,522
Neeraj Sachdeva, Md, MD
Gastroenterology — Payments: $20,208
Gastroenterology $20,208
Murtaza Parekh, Md, MD
Gastroenterology — Payments: $13,298
Gastroenterology $13,298